Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 41:1926-1932, doi:10.1016/S0735-1097(03)00426-1
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, M. A.

The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency

Results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias

Michael A. Lee, MD, FACC*,*, Richard Weachter, MD, FACC{dagger}, Scott Pollak, MD, FACC{ddagger}, Mark S. Kremers, MD, FACC§, Ajay M. Naik, MD||, Russell Silverman, MD, FACC, Joann Tuzi, RN**, Wayne Wang, MS**, Linda J. Johnson, PhD**, David E. Euler, PhD** ATTEST Investigators

* John Muir/Mount Diablo Medical Center, Walnut Creek, California, USA
{dagger} Ferrell-Duncan Clinic and Cox Medical Center, Springfield, Missouri, USA
{ddagger} Florida Heart Institute and Florida Hospital, Orlando, Florida, USA
§ MidCarolina Cardiology and Presbyterian Hospital, Charlotte, North Carolina, USA
|| Cedar-Sinai Medical Center and UCLA School of Medicine, Los Angeles, California, USA
St. Joseph’s Hospital Health Center, Syracuse, New York, USA
** Medtronic Inc., Minneapolis, Minnesota, USA



View larger version (29K):

[in a new window]
 
Figure 1 Cardiac compass report. The atrial pacing therapies were activated on January 20. The vertical dashed line indicates the last device interrogation. The atrial tachycardia (AT)/atrial fibrillation (AF) Patient Check indicates the days that the patient used his or her activator because of symptoms. The patient received the activator at the time of randomization. CV = cardioversion.

 


View larger version (17K):

[in a new window]
 
Figure 2 An atrial tachycardia (AT) episode that was terminated by Ramp therapy. The graph shows the intervals between atrial (A-A) and ventricular (V-V) events at episode onset, detection, first therapy, and termination. The Ramp therapy was initiated 3.8 min after detection and resulted in the immediate termination of the atrial tachyarrhythmia. AF = atrial fibrillation.

 


View larger version (32K):

[in a new window]
 
Figure 3 Histogram of atrial tachycardia/atrial fibrillation episode duration. The median episode frequency in each duration band was compared between the ON and OFF groups, and no significant differences were observed (p ≥ 0.17).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement